Metabiota Stock

metabiota.comHealthcare / Healthcare providers & servicesFounded: 2008Funding to Date: $42.11MM

Metabiota is a health big data tracking company providing data, analytics, advice, and training to help governments prepare for global health threats and mitigate their impacts.

Register To Buy and Sell Shares

For more details on financing and valuation for Metabiota, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Metabiota’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Metabiota.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Metabiota investors also invested in these private companies

Team

Management Team

Robert Mann
COO & President
Nathan Wolfe
Founder & Chairman
James Pitkow Ph.D
CTO
Michael Bell
CFO
Mary Guttieri Ph.D
Executive Vice President

Board Members

Nathan Wolfe
Metabiota
John DeLoche
RSTP
Riaz Valani
Self

Frequently Asked Questions About Metabiota’s Stock

plusminus
Can you buy Metabiota’s stock?
Metabiota is not publicly traded on NYSE or NASDAQ in the U.S. To buy Metabiota’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Metabiota’s stock?
Yes, you can sell stock of a private company like Metabiota. Forge can help you sell your Metabiota stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Metabiota’s stock price?
Metabiota is a privately held company and therefore does not have a public stock price. However, you may access Metabiota’s private market stock price with Forge Data.
plusminus
What is Metabiota’s stock ticker symbol?
Metabiota does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Want to know where epidemics are flaring up around the world? Metabiota has the tool for you
In an effort to inform the public of the health risks breaking out all over the world (or just to scare the bejeezus out of already paranoid people), the startup Metabiota has released a free-to-use epidemic tracker for all of the outbreaks monitored publicly around the world. The San Francisco-bas…
Metabiota Gains Government Momentum with Black & Veatch Sub-Contracts for Defense Threat Reduction Programs | Markets Insider
ARC and Metabiota begin parametric outbreak & epidemic insurance pilot | Artemis.bm
The African Risk Capacity (ARC), a parametric sovereign disaster risk insurer for African nations, has begun a pilot with the help of San Francisco based Metabiota to roll-out parametric insurance cover against disease outbreaks and epidemics. The new parametric outbreak & epidemic insurance product has been coming for some time, as ARC looks to expand its remit to cover new risks which will in turn increase the diversification within and efficiency of its sovereign risk pool. Metabiota is a company focused on risk analytics for epidemics and it has just begun the risk modelling work for the new ARC outbreak and epidemic insurance product. The goal is to help African Nations to better plan for and mitigate the risk of infectious disease outbreaks within their countries, providing an insurance product that will pay out rapidly should an outbreak show signs of developing, helped by the use of parametric triggers and backed by global reinsurance capacity. The pilot phase of the
Updated on: Feb 23, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.